[go: up one dir, main page]

FI902435A7 - Menetelmä 2-asyylialkonoinihappojen valmistamiseksi - Google Patents

Menetelmä 2-asyylialkonoinihappojen valmistamiseksi Download PDF

Info

Publication number
FI902435A7
FI902435A7 FI902435A FI902435A FI902435A7 FI 902435 A7 FI902435 A7 FI 902435A7 FI 902435 A FI902435 A FI 902435A FI 902435 A FI902435 A FI 902435A FI 902435 A7 FI902435 A7 FI 902435A7
Authority
FI
Finland
Prior art keywords
acylalkanoic
acids
preparation
acylalkanoic acids
Prior art date
Application number
FI902435A
Other languages
English (en)
Swedish (sv)
Other versions
FI902435A0 (fi
Inventor
Henrich H Paradies
Samir B Hanna
Bernd Schneider
Original Assignee
Medice Chem Pharm Fabrik Puetter Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medice Chem Pharm Fabrik Puetter Gmbh filed Critical Medice Chem Pharm Fabrik Puetter Gmbh
Publication of FI902435A0 publication Critical patent/FI902435A0/fi
Publication of FI902435A7 publication Critical patent/FI902435A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/15Preparation of carboxylic acids or their salts, halides or anhydrides by reaction of organic compounds with carbon dioxide, e.g. Kolbe-Schmitt synthesis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI902435A 1989-05-16 1990-05-16 Menetelmä 2-asyylialkonoinihappojen valmistamiseksi FI902435A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35226989A 1989-05-16 1989-05-16

Publications (2)

Publication Number Publication Date
FI902435A0 FI902435A0 (fi) 1990-05-16
FI902435A7 true FI902435A7 (fi) 1990-11-17

Family

ID=23384455

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902435A FI902435A7 (fi) 1989-05-16 1990-05-16 Menetelmä 2-asyylialkonoinihappojen valmistamiseksi

Country Status (16)

Country Link
US (1) US5380927A (fi)
EP (2) EP0398288B1 (fi)
JP (2) JPH03209344A (fi)
KR (1) KR920700613A (fi)
CN (2) CN1053010A (fi)
AT (1) ATE129230T1 (fi)
AU (3) AU643210B2 (fi)
CA (2) CA2016888A1 (fi)
DD (2) DD300688A5 (fi)
DE (3) DE4015781A1 (fi)
FI (1) FI902435A7 (fi)
HU (2) HUT56263A (fi)
IL (2) IL94420A0 (fi)
NO (2) NO902190L (fi)
WO (1) WO1990014073A1 (fi)
ZA (2) ZA903759B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
EP0584108B1 (en) 1991-05-13 2000-08-16 The Boots Company PLC Pharmaceutical composition comprising ibuprofen salt
AU5018693A (en) * 1992-09-21 1994-04-12 Upjohn Company, The Sustained-release protein formulations
CA2150355C (en) * 1992-12-02 2008-03-11 Robert Hardy Process of resolving phenylpropionic acids using alpha-methylbenzylamine
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
EP0695179A1 (en) * 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Transdermal antiinflammatory composition
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
DK106293D0 (da) * 1993-09-22 1993-09-22 Joergen Rasmussen Kapsel til indbringning af laegemidler i kreaturmaver
US5574183A (en) * 1995-01-24 1996-11-12 Albemarle Corporation Preparation of optically active aliphatic carboxylic acids
US20060030826A1 (en) * 1996-06-04 2006-02-09 Vance Products Incorporated,d/b/a Cook Urological Incorporated Implantable medical device with anti-neoplastic drug
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
FR2878746B1 (fr) 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
EP1690528A1 (de) * 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
US11639326B2 (en) * 2017-04-06 2023-05-02 Sri International Continuous flow synthesis of ibuprofen
GB2568698A (en) * 2017-11-23 2019-05-29 Akl Res & Development Ltd Formulation
CN112457182A (zh) * 2020-12-16 2021-03-09 江苏慧聚药业有限公司 一种氟比洛芬杂质的制备方法
CN119492694B (zh) * 2024-11-12 2025-09-30 科顺防水科技股份有限公司 化学阻根剂手性分布的测量方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942743A (en) * 1959-05-22 1963-11-27 Welloome Foundation Ltd Oestrogen preparations and the manufacture thereof
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
FR1591573A (fi) * 1968-05-10 1970-05-04
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
JPS5335069B2 (fi) * 1973-01-29 1978-09-25
US3927084A (en) * 1973-01-29 1975-12-16 Nisshin Flour Milling Co Process for the production of 2(4-alkylphenyl)propionic acid
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica
FR2287217A1 (fr) * 1974-10-08 1976-05-07 Hommel Ag Nouveaux acides phenylalcanoiques substitues et leurs derives, ainsi que procede de leur preparation et medicaments
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
GB1480971A (en) * 1975-04-03 1977-07-27 Prodotti Antibiotici Spa Preparation of isobutylphenyl compounds
IT1051442B (it) * 1975-05-22 1981-04-21 Ind Chimica Prodotti Francis S Procedimento per la preparazione di derivati dell acido para isobutil fenilacetico
US4209638A (en) * 1977-03-08 1980-06-24 The Boots Company Limited Preparation of therapeutic agents
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS6072976A (ja) * 1983-09-30 1985-04-25 Sagami Chem Res Center 水素化アルミニウムリチウム系不斉還元剤
DE3567209D1 (en) * 1984-04-06 1989-02-09 Zambon Spa Optically active ketals, processes for their preparation and their use in the synthesis of apha-arylakanoic acids
JPS6112294A (ja) * 1984-06-26 1986-01-20 Kureha Chem Ind Co Ltd 2−(置換フエニル)プロピオン酸の製造方法
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
IT1201408B (it) * 1985-03-22 1989-02-02 Montedison Spa Processo per la preparazione biotecnologica di acidi alfa-arilalcanoici otticamente attivi
GB8514489D0 (en) * 1985-06-07 1985-07-10 Shell Int Research Producing 2-arylpropionic acids
JPS632935A (ja) * 1986-06-20 1988-01-07 Sumitomo Chem Co Ltd 光学活性アルコ−ル類の製造方法
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
US4868214A (en) * 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US4962124A (en) * 1987-11-17 1990-10-09 Analgesic Associates Onset-hastened/enhanced antipyretic response

Also Published As

Publication number Publication date
NO905132L (no) 1990-11-29
HUT56263A (en) 1991-08-28
DE4015781A1 (de) 1990-12-13
HUT54610A (en) 1991-03-28
EP0398288A2 (de) 1990-11-22
US5380927A (en) 1995-01-10
KR920700613A (ko) 1992-08-10
FI902435A0 (fi) 1990-05-16
HU903057D0 (en) 1990-09-28
DE59009781D1 (de) 1995-11-23
WO1990014073A1 (de) 1990-11-29
ZA903759B (en) 1991-02-27
DD300404A5 (de) 1992-06-11
CA2016888A1 (en) 1990-11-16
CA2016887A1 (en) 1990-11-16
HU904479D0 (en) 1991-06-28
AU5509290A (en) 1990-11-22
NO905132D0 (no) 1990-11-27
ZA903756B (en) 1991-02-27
JPH03506040A (ja) 1991-12-26
AU643210B2 (en) 1993-11-11
NO902190D0 (no) 1990-05-16
JPH03209344A (ja) 1991-09-12
IL94420A0 (en) 1991-03-10
CN1050373A (zh) 1991-04-03
NO902190L (no) 1990-11-19
DE4015794A1 (de) 1990-11-29
ATE129230T1 (de) 1995-11-15
EP0398288A3 (de) 1992-01-15
DD300688A5 (de) 1992-07-02
CN1053010A (zh) 1991-07-17
IL94419A0 (en) 1991-03-10
AU3987893A (en) 1993-08-19
EP0398287A1 (de) 1990-11-22
AU5509190A (en) 1990-11-22
EP0398288B1 (de) 1995-10-18

Similar Documents

Publication Publication Date Title
FI870035A7 (fi) Menetelmä 2-aryylipropionihappojen valmistamiseksi
FI902435A7 (fi) Menetelmä 2-asyylialkonoinihappojen valmistamiseksi
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI883997A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
IS3589A7 (is) Aðferð við framleiðslu á efnasambandinu Indenoindoles I
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
FI904117A7 (fi) Menetelmä alkoksialkylideenimalonihappoestereiden valmistamiseksi
FI890188A7 (fi) Menetelmä 1-hydroksialkyyli-2-metyyli-5-nitroimidatsolien valmistamiseksi
FI902417A7 (fi) Menetelmä 3-eksometyleenikefaamisulfoksidiesterien valmistamiseksi
PT88431A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
FI891371L (fi) Menetelmä 4-halogeeni-3-okso-2-alkoksi-imino-voihappoesterien valmistamiseksi
FI904570A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi I
FI913464A7 (fi) Menetelmä 1-hydroksimetyylipyratsolien valmistamiseksi
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
FI891191A7 (fi) Menetelmä 3-eksometyleeni-kefam-johdannaisten valmistamiseksi
FR2643902B1 (fr) Procede de preparation de n-allylmetatrifluoromethylaniline
FI901358A0 (fi) Menetelmä fluorifenolien valmistamiseksi
FI902158A7 (fi) Menetelmä kyllästämättömien B,V-happojen valmistamiseksi
FI910662A7 (fi) Menetelmä 7-amino-3-metoksimetyyli-kef-3-emi-4-karboksyylihapon valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: MEDICE CHEM.-PHARM. FABRIK PUETTER GMBH